Long SA - Search Results

1

IL-2 therapy in type 1 diabetes: "Trials" and tribulations.

Long SA, Buckner JH, Greenbaum CJ. Long SA, et al. Clin Immunol. 2013 Dec;149(3):324-31. doi: 10.1016/j.clim.2013.02.005. Epub 2013 Feb 22. Clin Immunol. 2013. PMID: 23499139 Review.

2

Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and Anti-CD28 antibodies.

Kalamasz D, Long SA, Taniguchi R, Buckner JH, Berenson RJ, Bonyhadi M. Kalamasz D, et al. Among authors: long sa. J Immunother. 2004 Sep-Oct;27(5):405-18. doi: 10.1097/00002371-200409000-00010. J Immunother. 2004. PMID: 15314550

3

Combination of rapamycin and IL-2 increases de novo induction of human CD4(+)CD25(+)FOXP3(+) T cells.

Long SA, Buckner JH. Long SA, et al. J Autoimmun. 2008 Jun;30(4):293-302. doi: 10.1016/j.jaut.2007.12.012. Epub 2008 Mar 3. J Autoimmun. 2008. PMID: 18313267 Free PMC article.

4

Functional islet-specific Treg can be generated from CD4+CD25- T cells of healthy and type 1 diabetic subjects.

Long SA, Walker MR, Rieck M, James E, Kwok WW, Sanda S, Pihoker C, Greenbaum C, Nepom GT, Buckner JH. Long SA, et al. Eur J Immunol. 2009 Feb;39(2):612-20. doi: 10.1002/eji.200838819. Eur J Immunol. 2009. PMID: 19180473 Free PMC article.

5

CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta.

Bollyky PL, Falk BA, Long SA, Preisinger A, Braun KR, Wu RP, Evanko SP, Buckner JH, Wight TN, Nepom GT. Bollyky PL, et al. Among authors: long sa. J Immunol. 2009 Aug 15;183(4):2232-41. doi: 10.4049/jimmunol.0900191. Epub 2009 Jul 27. J Immunol. 2009. PMID: 19635906 Free PMC article.

6

Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.

Long SA, Cerosaletti K, Bollyky PL, Tatum M, Shilling H, Zhang S, Zhang ZY, Pihoker C, Sanda S, Greenbaum C, Buckner JH. Long SA, et al. Diabetes. 2010 Feb;59(2):407-15. doi: 10.2337/db09-0694. Epub 2009 Oct 29. Diabetes. 2010. PMID: 19875613 Free PMC article.

7

An autoimmune-associated variant in PTPN2 reveals an impairment of IL-2R signaling in CD4(+) T cells.

Long SA, Cerosaletti K, Wan JY, Ho JC, Tatum M, Wei S, Shilling HG, Buckner JH. Long SA, et al. Genes Immun. 2011 Mar;12(2):116-25. doi: 10.1038/gene.2010.54. Epub 2010 Dec 23. Genes Immun. 2011. PMID: 21179116 Free PMC article.

8

CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game.

Long SA, Buckner JH. Long SA, et al. J Immunol. 2011 Sep 1;187(5):2061-6. doi: 10.4049/jimmunol.1003224. J Immunol. 2011. PMID: 21856944 Free PMC article. Review.

9

Low-dose antigen promotes induction of FOXP3 in human CD4+ T cells.

Long SA, Rieck M, Tatum M, Bollyky PL, Wu RP, Muller I, Ho JC, Shilling HG, Buckner JH. Long SA, et al. J Immunol. 2011 Oct 1;187(7):3511-20. doi: 10.4049/jimmunol.1003880. Epub 2011 Aug 24. J Immunol. 2011. PMID: 21865550 Free PMC article.

10

Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function.

Long SA, Rieck M, Sanda S, Bollyky JB, Samuels PL, Goland R, Ahmann A, Rabinovitch A, Aggarwal S, Phippard D, Turka LA, Ehlers MR, Bianchine PJ, Boyle KD, Adah SA, Bluestone JA, Buckner JH, Greenbaum CJ; Diabetes TrialNet and the Immune Tolerance Network. Long SA, et al. Diabetes. 2012 Sep;61(9):2340-8. doi: 10.2337/db12-0049. Epub 2012 Jun 20. Diabetes. 2012. PMID: 22721971 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page